FDA to Prioritize Full Approval for Pfizer COVID Vaccine

FRIDAY, July 16, 2021 — Pfizer Inc. announced on Friday that the U.S. Food and Drug Administration has granted priority review to its COVID-19 vaccine, positioning the vaccine for full approval by January.
The Pfizer vaccine has been administered…
Source: Topamax